Vanderbilt: Interdisciplinary Melanoma Research Brings Understanding of Cellular Resistance to Cancer Treatment, Opening Doors to New Cures
October 22, 2020
October 22, 2020
NASHVILLE, Tennessee, Oct. 22 (TNSJou) -- Vanderbilt University issued the following news:
A Vanderbilt cancer systems biology team has identified the enzymes that keep tumor cells growing in the presence of drug treatment, opening the door to stopping these cells dead in their tracks.
An article, "An Integrative Gene Expression and Mathematical Flux-Balance Analysis Identifies Targetable Redox Vulnerabilities in Melanoma Cells," was published in the journal C . . .
A Vanderbilt cancer systems biology team has identified the enzymes that keep tumor cells growing in the presence of drug treatment, opening the door to stopping these cells dead in their tracks.
An article, "An Integrative Gene Expression and Mathematical Flux-Balance Analysis Identifies Targetable Redox Vulnerabilities in Melanoma Cells," was published in the journal C . . .